• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: CPI - DEL CARIBE INGEVITY; IMPLANTABLE LEAD

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

CPI - DEL CARIBE INGEVITY; IMPLANTABLE LEAD Back to Search Results
Model Number 7742
Device Problems Capturing Problem (2891); Human-Device Interface Problem (2949)
Patient Problems Chest Pain (1776); Cardiac Perforation (2513); Pericardial Effusion (3271)
Event Date 08/14/2018
Event Type  Injury  
Manufacturer Narrative
The product is expected to be returned for analysis.This report will be updated upon return and completion of analysis.
 
Event Description
Boston scientific received information that the patient implanted with these right atrial (ra) and right ventricular (rv) leads presented to the hospital complaining of chest pain; increased rv pacing thresholds were also reported.A rv perforation was confirmed.While a ra perforation could not be confirmed there was evidence of effusion in the area.Both leads were explanted and replaced.No additional adverse patient effects were reported.
 
Manufacturer Narrative
Upon receipt at our post market quality assurance laboratory, a thorough evaluation of the lead was performed.Testing was completed to assess lead electrical performance and inner insulation integrity.Measurements throughout these tests were within normal limits.Microscopic inspections of the terminal pin assembly, lead body, and electrode tip found no anomalies.Laboratory testing was unable to reproduce the reported clinical observations and detailed analysis did not reveal any abnormalities.Laboratory analysis did not identify any lead characteristics that would have caused or contributed to the reported clinical observations.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
INGEVITY
Type of Device
IMPLANTABLE LEAD
Manufacturer (Section D)
CPI - DEL CARIBE
guidant puerto rico b. v.
dorado PR
Manufacturer (Section G)
CPI - DEL CARIBE
guidant puerto rico b. v.
dorado PR
Manufacturer Contact
tim degroot
4100 hamline ave. n
st. paul, MN 
6515826168
MDR Report Key7981875
MDR Text Key124275662
Report Number2124215-2018-16353
Device Sequence Number1
Product Code LWP
Combination Product (y/n)N
PMA/PMN Number
P150012/S000
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type company representative
Reporter Occupation Non-Healthcare Professional
Type of Report Initial,Followup
Report Date 10/03/2018
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received10/18/2018
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? Yes
Device Operator Lay User/Patient
Device Expiration Date12/30/2019
Device Model Number7742
Was Device Available for Evaluation? Device Returned to Manufacturer
Date Returned to Manufacturer09/25/2018
Was the Report Sent to FDA? Yes
Date Manufacturer Received10/03/2018
Was Device Evaluated by Manufacturer? Yes
Date Device Manufactured12/30/2017
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Patient Outcome(s) Hospitalization; Life Threatening; Required Intervention;
-
-